Skip to main content
Equibles

MORGAN STANLEY

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 895421 NEW YORK, NY
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$194,472
-$42,990 QoQ
Shares Held
15,241
-11.7% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 103 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 83% Shared 0% None 17%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. TNXP ranks #325 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in TNXP

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $194,472 15,241
2026-03-31 $237,462 17,270
2025-12-31 $656,631 42,038
2025-09-30 $378,704 15,675
2025-06-30 $681,028 18,928
2025-03-31 $47,863 2,677
2024-12-31 $6,036 18,294
2024-09-30 $36 249
2024-06-30 $174 251
2024-03-31 $1,490 7,844
2023-12-31 $3,184 7,962
2023-09-30 $4,998 9,089
2023-06-30 $16,526 10,461
2023-03-31 $420,060 711,969
2022-12-31 $83,810 214,901
2022-09-30 $494,789 933,572
2022-06-30 $1,401,008 886,716
2022-03-31 $124,779 542,527
2021-12-31 $315,848 877,361
2021-09-30 $157,468 262,449
2021-06-30 $314,115 282,987
2021-03-31 $361,397 282,342
2020-12-31 $408 602
2020-09-30 $504 600
2020-06-30 $0 2
2020-03-31 $0 1